8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Mar 13, 2026·SEC
Material company update
Feb 26, 2026·SEC
Progyny, Inc.(PGNY)Earnings, Financials & Key Ratios
PGNY•NASDAQ
40.1× P/E·Price updated Jun 19, 2026
AboutProgyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.Show more
- Revenue$1.29B+10.4%
- EBITDA$90M+27.7%
- Net Income$59M+7.7%
- EPS (Diluted)0.65+14.0%
- Gross Margin23.63%+8.9%
- EBITDA Margin7%+15.7%
- Operating Margin6.62%+14.5%
- Net Margin4.54%-2.5%
- ROE12.48%+12.0%
PGNY Key Insights
Progyny, Inc. (PGNY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Momentum leader: RS Rating 84 (top 16%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 30.2%
- ✓Share count reduced 6.3% through buybacks
- ✓Efficient asset utilization: 1.7x turnover
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PGNY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PGNY Price & Volume
Progyny, Inc. (PGNY) stock price & volume — 10-year historical chart
Loading chart...
PGNY Growth Metrics
Progyny, Inc. (PGNY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years30.17%
3 Years17.87%
TTM6.59%
Profit CAGR
10 Years-
5 Years4.72%
3 Years24.45%
TTM28.95%
EPS CAGR
10 Years-
5 Years6.7%
3 Years29.4%
TTM35.09%
Return on Capital
10 Years-0.14%
5 Years13.19%
3 Years14.61%
Last Year17.43%
PGNY Recent Earnings
Progyny, Inc. (PGNY) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$0.29+13.3%
$0.26
Rev
$329M+0.6%
$326M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$0.15+2.0%
$0.15
Rev
$318M+3.6%
$307M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$0.45+15.4%
$0.39
Rev
$313M-0.3%
$314M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.48+9.1%
$0.44
Rev
$333M+11.2%
$299M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $0.29vs $0.26+13.3% | $329Mvs $326M+0.6% |
| Q1 2026 | Feb 26, 2026 | $0.15vs $0.15+2.0% | $318Mvs $307M+3.6% |
| Q4 2025 | Nov 6, 2025 | $0.45vs $0.39+15.4% | $313Mvs $314M-0.3% |
| Q3 2025 | Aug 7, 2025 | $0.48vs $0.44+9.1% | $333Mvs $299M+11.2% |
Based on last 12 quarters of dataView full earnings history →
PGNY Peer Comparison
Progyny, Inc. (PGNY) competitors in Payer and Benefits Administration — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 LFST | 3.48B | 8.98 | 449 | 13.85% | 1.55% | 1.56% | 0.13 | |
 GDRX | 922.03M | 2.66 | 31.18 | 0.57% | 3.74% | 4.75% | 0.10 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 | |
 CI | 73.63B | 279.27 | 12.60 | 11.26% | 2.26% | 15.08% | 0.75 | |
 UNH | 363.94B | 400.96 | 30.31 | 11.81% | 2.68% | 11.54% | 0.77 | |
 ELV | 84.37B | 388.50 | 15.47 | 12.62% | 2.62% | 11.92% | 0.75 | |
 HUM | 43.3B | 360.65 | 36.65 | 10.06% | 0.82% | 6.17% | 0.73 |
Compare PGNY vs Peers
Progyny, Inc. (PGNY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PGNY Income Statement
Progyny, Inc. (PGNY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 48.58M | 105.4M | 229.68M | 344.86M | 500.62M | 786.91M | 1.09B | 1.17B | 1.29B | 1.29B |
Revenue Growth % | - | 116.94% | 117.92% | 50.15% | 45.17% | 57.19% | 38.34% | 7.22% | 10.4% | 6.59% |
Cost of Goods Sold | 41.18M | 85.97M | 184.18M | 274.8M | 388.49M | 619.59M | 849.8M | 913.86M | 984.18M | 981.37M |
COGS % of Revenue | 84.77% | 81.56% | 80.19% | 79.68% | 77.6% | 78.74% | 78.06% | 78.29% | 76.37% | - |
Gross Profit | 7.4M▲ 0% | 19.43M▲ 162.6% | 45.51M▲ 134.2% | 70.06M▲ 54.0% | 112.14M▲ 60.1% | 167.32M▲ 49.2% | 238.8M▲ 42.7% | 253.36M▲ 6.1% | 304.48M▲ 20.2% | 311.76M▲ 0% |
Gross Margin % | 15.23% | 18.44% | 19.81% | 20.32% | 22.4% | 21.26% | 21.94% | 21.71% | 23.63% | 24.11% |
Gross Profit Growth % | - | 162.62% | 134.15% | 53.96% | 60.06% | 49.22% | 42.72% | 6.1% | 20.18% | - |
Operating Expenses | 18.41M | 22.89M | 35.83M | 61.71M | 79.8M | 143.98M | 176.62M | 185.91M | 219.21M | 215.27M |
OpEx % of Revenue | 37.88% | 21.71% | 15.6% | 17.89% | 15.94% | 18.3% | 16.22% | 15.93% | 17.01% | - |
Selling, General & Admin | 18.41M | 22.89M | 35.83M | 61.71M | 79.8M | 143.98M | 176.62M | 185.91M | 219.21M | 215.27M |
SG&A % of Revenue | 37.88% | 21.71% | 15.6% | 17.89% | 15.94% | 18.3% | 16.22% | 15.93% | 17.01% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -11.01M▲ 0% | -3.45M▲ 68.6% | 9.68M▲ 380.3% | 8.35M▼ 13.7% | 32.34M▲ 287.4% | 23.34M▼ 27.8% | 62.18M▲ 166.4% | 67.45M▲ 8.5% | 85.28M▲ 26.4% | 96.49M▲ 0% |
Operating Margin % | -22.65% | -3.28% | 4.21% | 2.42% | 6.46% | 2.97% | 5.71% | 5.78% | 6.62% | 7.46% |
Operating Income Growth % | - | 68.63% | 380.33% | -13.73% | 287.4% | -27.83% | 166.42% | 8.48% | 26.42% | - |
EBITDA | -9.45M | -1.57M | 11.81M | 10.25M | 33.64M | 24.94M | 64.47M | 70.63M | 90.22M | 100.33M |
EBITDA Margin % | -19.44% | -1.49% | 5.14% | 2.97% | 6.72% | 3.17% | 5.92% | 6.05% | 7% | 7.76% |
EBITDA Growth % | - | 83.39% | 852.71% | -13.18% | 228.08% | -25.86% | 158.46% | 9.56% | 27.74% | 30.86% |
D&A (Non-Cash Add-back) | 1.56M | 1.88M | 2.13M | 1.91M | 1.3M | 1.6M | 2.28M | 3.17M | 4.95M | 3.84M |
EBIT | -11.01M | -3.45M | 9.68M | 8.35M | 32.34M | 23.34M | 62.18M | 67.45M | 95.43M | 104.27M |
Net Interest Income | -740K | -497K | -58K | 121K | 461K | 814K | 8.51M | 15.75M | 0 | 2.72M |
Interest Income | 0 | 0 | 0 | 121K | 461K | 814K | 8.51M | 15.75M | 0 | 2.72M |
Interest Expense | 740K | 497K | 58K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | -1.45M | -3.44M | -18.23M | 331K | 95K | 1.1M | 8.51M | 15.75M | 10.15M | 9.29M |
Pretax Income | -12.46M▲ 0% | -6.89M▲ 44.7% | -8.56M▼ 24.1% | 8.68M▲ 201.4% | 32.44M▲ 273.7% | 24.44M▼ 24.6% | 70.69M▲ 189.2% | 83.2M▲ 17.7% | 95.43M▲ 14.7% | 105.78M▲ 0% |
Pretax Margin % | -25.64% | -6.54% | -3.73% | 2.52% | 6.48% | 3.11% | 6.49% | 7.13% | 7.41% | 8.18% |
Income Tax | -3K | -1.78M | 12K | -37.78M | -33.33M | -5.92M | 8.65M | 28.87M | 36.91M | 38.09M |
Effective Tax Rate % | 0.02% | 25.78% | -0.14% | -435.3% | -102.77% | -24.21% | 12.24% | 34.69% | 38.68% | 36% |
Net Income | -12.45M▲ 0% | 661K▲ 105.3% | -8.57M▼ 1396.4% | 46.46M▲ 642.2% | 65.77M▲ 41.6% | 30.36M▼ 53.8% | 62.04M▲ 104.4% | 54.34M▼ 12.4% | 58.52M▲ 7.7% | 67.69M▲ 0% |
Net Margin % | -25.63% | 0.63% | -3.73% | 13.47% | 13.14% | 3.86% | 5.7% | 4.66% | 4.54% | 5.23% |
Net Income Growth % | - | 105.31% | -1396.37% | 642.18% | 41.56% | -53.84% | 104.35% | -12.41% | 7.7% | 28.95% |
Net Income (Continuing) | -12.46M | -5.12M | -8.57M | 46.46M | 65.77M | 30.36M | 62.04M | 54.34M | 58.52M | 67.69M |
Discontinued Operations | 4K | 5.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -2.19▲ 0% | 0.01▲ 100.4% | -0.10▼ 1334.6% | 0.47▲ 570.0% | 0.66▲ 40.4% | 0.30▼ 54.5% | 0.62▲ 106.7% | 0.57▼ 8.1% | 0.65▲ 14.0% | 0.80▲ 0% |
EPS Growth % | - | 100.37% | - | 570% | 40.43% | -54.55% | 106.67% | -8.06% | 14.04% | 35.09% |
EPS (Basic) | -2.19 | 0.01 | -0.10 | 0.54 | 0.74 | 0.33 | 0.65 | 0.59 | 0.68 | - |
Diluted Shares Outstanding | 5.69M | 81.56M | 83.57M | 99.06M | 100.36M | 99.96M | 100.67M | 95.45M | 89.46M | 84.76M |
Basic Shares Outstanding | 5.69M | 81.56M | 83.57M | 85.72M | 89.11M | 92.2M | 95.02M | 91.48M | 85.23M | 80.92M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
PGNY Balance Sheet
Progyny, Inc. (PGNY) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 16.77M | 24.54M | 132.44M | 190.22M | 258.54M | 433.86M | 640.41M | 472.72M | 551.77M | 501.55M |
Cash & Short-Term Investments | 4.69M | 127K | 80.38M | 109.3M | 119.42M | 189.3M | 371.09M | 227.95M | 310.1M | 226.15M |
Cash Only | 4.69M | 127K | 80.38M | 70.31M | 91.41M | 120.08M | 97.3M | 162.31M | 112.24M | 132.65M |
Short-Term Investments | 0 | 0 | 0 | 38.99M | 28M | 69.22M | 273.79M | 65.64M | 197.86M | 93.5M |
Accounts Receivable | 11.37M | 23.32M | 47.06M | 75.66M | 134.56M | 240.07M | 241.87M | 235.32M | 220.29M | 263.61M |
Days Sales Outstanding | 85.44 | 80.77 | 74.78 | 80.08 | 98.1 | 111.35 | 81.1 | 73.59 | 62.39 | 71.15 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
Other Current Assets | 0 | 200K | 0 | 0 | 0 | 4.49M | 27.45M | 9.44M | 21.39M | 11.79M |
Total Non-Current Assets | 18.19M | 16.79M | 17.99M | 63.7M | 99.53M | 109.13M | 116.21M | 134.38M | 190.66M | 196.79M |
Property, Plant & Equipment | 597K | 776K | 3.08M | 12.07M | 12.83M | 15.27M | 27.82M | 29.63M | 54.92M | 59.98M |
Fixed Asset Turnover | 81.38x | 135.82x | 74.50x | 28.58x | 39.01x | 51.52x | 39.13x | 39.39x | 23.47x | 24.43x |
Goodwill | 11.88M | 11.88M | 11.88M | 11.88M | 11.88M | 11.88M | 11.88M | 15.53M | 19.98M | 19.88M |
Intangible Assets | 5.34M | 3.86M | 2.38M | 1.21M | 599K | 99K | 0 | 1.3M | 6.22M | 5.97M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 925K |
Other Non-Current Assets | 372K | 272K | 652K | 573K | 2.94M | 3.99M | 3.4M | 2.98M | 16.54M | 16.95M |
Total Assets | 34.96M▲ 0% | 41.32M▲ 18.2% | 150.43M▲ 264.0% | 253.93M▲ 68.8% | 358.06M▲ 41.0% | 542.99M▲ 51.6% | 756.62M▲ 39.3% | 607.1M▼ 19.8% | 742.43M▲ 22.3% | 698.34M▲ 0% |
Asset Turnover | 1.39x | 2.55x | 1.53x | 1.36x | 1.40x | 1.45x | 1.44x | 1.92x | 1.74x | 1.73x |
Asset Growth % | - | 18.2% | 264.04% | 68.8% | 41.01% | 51.64% | 39.34% | -19.76% | 22.29% | 47.33% |
Total Current Liabilities | 17.77M | 30.2M | 36.16M | 77.79M | 98.82M | 159.54M | 185.95M | 168.63M | 202.39M | 235.74M |
Accounts Payable | 5.13M | 15.58M | 19.39M | 43.51M | 61.4M | 109.29M | 125.43M | 95.1M | 124.07M | 157.83M |
Days Payables Outstanding | 45.47 | 66.14 | 38.42 | 57.8 | 57.69 | 64.38 | 53.87 | 37.98 | 46.01 | 50.72 |
Short-Term Debt | 3.56M | 253K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.03M |
Deferred Revenue (Current) | 7.13M | 9.39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 6.73M | 11.64M | 13M | 7.69M | 12.26M | 8.88M | 13.05M | 19.87M | 78.32M | 73.89M |
Current Ratio | 0.94x | 0.81x | 3.66x | 2.45x | 2.62x | 2.72x | 3.44x | 2.80x | 2.73x | 2.13x |
Quick Ratio | 0.94x | 0.81x | 3.66x | 2.45x | 2.62x | 2.72x | 3.44x | 2.80x | 2.73x | 2.13x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | 20.43 |
Total Non-Current Liabilities | 6.5M | 106.24M | 0 | 9.19M | 7.42M | 6.48M | 17.24M | 16.41M | 24M | 23.25M |
Long-Term Debt | 1.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 8.32M | 7.42M | 6.48M | 17.24M | 16.41M | 24M | 97.49M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4.87M | 0 | 0 | 876K | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 24.27M | 30.2M | 36.16M | 86.98M | 106.24M | 166.02M | 203.19M | 185.04M | 226.39M | 258.99M |
Total Debt | 5.19M | 253K | 0 | 9.55M | 8.65M | 7.71M | 19.39M | 19.27M | 24M | 27.28M |
Net Debt | 497K | 126K | -80.38M | -60.76M | -82.76M | -112.36M | -77.91M | -143.04M | -88.24M | -105.37M |
Debt / Equity | 0.49x | 0.02x | - | 0.06x | 0.03x | 0.02x | 0.04x | 0.05x | 0.05x | 0.06x |
Debt / EBITDA | - | - | - | 0.93x | 0.26x | 0.31x | 0.30x | 0.27x | 0.27x | 0.27x |
Net Debt / EBITDA | - | - | -6.81x | -5.93x | -2.46x | -4.51x | -1.21x | -2.03x | -0.98x | -1.05x |
Interest Coverage | -14.87x | -6.95x | 166.84x | - | - | - | - | - | - | - |
Total Equity | 10.69M▲ 0% | 11.12M▲ 4.0% | 114.27M▲ 927.4% | 166.95M▲ 46.1% | 251.82M▲ 50.8% | 376.97M▲ 49.7% | 553.43M▲ 46.8% | 422.06M▼ 23.7% | 516.04M▲ 22.3% | 439.34M▲ 0% |
Equity Growth % | - | 4.04% | 927.43% | 46.1% | 50.84% | 49.7% | 46.81% | -23.74% | 22.27% | 57.98% |
Book Value per Share | 1.88 | 0.14 | 1.37 | 1.69 | 2.51 | 3.77 | 5.50 | 4.42 | 5.77 | 5.18 |
Total Shareholders' Equity | 10.69M | 11.12M | 114.27M | 166.95M | 251.82M | 376.97M | 553.43M | 422.06M | 516.04M | 439.34M |
Common Stock | 1K | 1K | 8K | 9K | 9K | 9K | 9K | 9K | 9K | 9K |
Retained Earnings | -104.56M | -104.85M | -113.48M | -68.19M | -2.42M | 27.93M | 89.97M | 144.31M | 202.83M | 227.06M |
Treasury Stock | 0 | -884K | -1.01M | -1.01M | -1.01M | -1.01M | -1.01M | -303.89M | -388.07M | -505.76M |
Accumulated OCI | -83K | -483K | -150.43M | 1K | -93K | 501K | 2.82M | 39K | 498K | 277K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PGNY Cash Flow Statement
Progyny, Inc. (PGNY) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -9.47M | 2.27M | -1.53M | 36.2M | 26.04M | 80.39M | 188.81M | 179.1M | 210.19M | 203.25M |
Operating CF Margin % | -19.5% | 2.16% | -0.67% | 10.5% | 5.2% | 10.22% | 17.34% | 15.34% | 16.31% | - |
Operating CF Growth % | - | 123.98% | -167.52% | 2460.04% | -28.08% | 208.77% | 134.86% | -5.14% | 17.36% | 0.97% |
Net Income | -12.45M | 661K | -8.57M | 46.46M | 65.77M | 30.36M | 62.04M | 54.34M | 58.52M | 67.69M |
Depreciation & Amortization | 1.56M | 1.88M | 2.13M | 1.91M | 1.3M | 1.6M | 2.28M | 3.17M | 4.95M | 5.32M |
Stock-Based Compensation | 1.56M | 3M | 5.06M | 12.82M | 0 | 100.75M | 122.61M | 128.13M | 131.87M | 32.38M |
Deferred Taxes | -3K | -1.78M | 12K | -37.97M | -33.3M | -6.62M | 3.75M | -10.46M | -8.12M | -8.12M |
Other Non-Cash Items | 1.29M | -1.85M | 19.78M | 5.64M | 43.53M | 13.79M | 15.56M | 15.7M | 20.17M | 102.85M |
Working Capital Changes | -1.43M | 354K | -19.95M | 7.35M | -51.26M | -59.49M | -17.42M | -11.78M | 2.8M | 3.11M |
Change in Receivables | -2.04M | -12.78M | -25.34M | -35.34M | -68.68M | -119.3M | -21.74M | -9.87M | -5.12M | 16.84M |
Change in Inventory | 1.81M | 2.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -909K | 10.45M | 3.5M | 25.01M | 17.84M | 47.69M | 16.23M | -30.27M | 28.75M | 12.77M |
Cash from Investing | -612K | 1.9M | -2.76M | -40.03M | 8.77M | -43.87M | -200.53M | 195.79M | -159.01M | 32.19M |
Capital Expenditures | -612K | -579K | -2.96M | -1.04M | -2.13M | -3.24M | -3.64M | -5.41M | -18.41M | -21.91M |
CapEx % of Revenue | 1.26% | 0.55% | 1.29% | 0.3% | 0.43% | 0.41% | 0.33% | 0.46% | 1.43% | 1.69% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.3M | -9.34M | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 0 | 2.48M | 200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | 11.77M | -8.74M | 84.55M | -6.25M | -13.7M | -7.86M | -11.07M | -309.88M | -99.36M | -216.1M |
Debt Issued (Net) | -3.26M | -5.1M | -253K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 15M | -3.71M | 81.03M | 2.68M | 4.27M | 4.22M | 6.13M | -300.28M | -80.43M | -198.99M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -3.71M | -185K | 0 | 0 | 0 | 0 | -300.28M | -81.66M | -200.26M |
Other Financing | 25K | 65K | 3.76M | -8.93M | -17.97M | -12.09M | -17.2M | -9.6M | -18.93M | -17.11M |
Net Change in Cash | 1.68M▲ 0% | -4.56M▼ 371.7% | 80.25M▲ 1858.4% | -10.08M▼ 112.6% | 21.11M▲ 309.5% | 28.66M▲ 35.8% | -22.78M▼ 179.5% | 65.02M▲ 385.4% | -48.12M▼ 174.0% | 23.44M▲ 0% |
Free Cash Flow | -10.09M▲ 0% | 1.69M▲ 116.8% | -4.49M▼ 365.2% | 35.17M▲ 883.2% | 23.91M▼ 32.0% | 77.15M▲ 222.7% | 185.17M▲ 140.0% | 173.7M▼ 6.2% | 191.78M▲ 10.4% | 181.33M▲ 0% |
FCF Margin % | -20.76% | 1.61% | -1.95% | 10.2% | 4.78% | 9.8% | 17.01% | 14.88% | 14.88% | 14.02% |
FCF Growth % | - | 116.79% | -365.21% | 883.21% | -32.01% | 222.71% | 140% | -6.19% | 10.41% | -7.38% |
FCF per Share | -1.77 | 0.02 | -0.05 | 0.36 | 0.24 | 0.77 | 1.84 | 1.82 | 2.14 | 2.14 |
FCF Conversion (FCF/Net Income) | 0.76x | 3.44x | 0.18x | 0.78x | 0.40x | 2.65x | 3.04x | 3.30x | 3.59x | 2.68x |
Interest Paid | 0 | 0 | 176K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.45M | 0 | 23.94M |
PGNY Key Ratios
Progyny, Inc. (PGNY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 6.06% | -13.67% | 33.04% | 31.41% | 9.66% | 13.34% | 11.14% | 12.48% | 13.34% |
Return on Invested Capital (ROIC) | -23.08% | 32.16% | 8.94% | 17.62% | 8.07% | 12.6% | 13.41% | 18.1% | 17.82% |
Gross Margin | 18.44% | 19.81% | 20.32% | 22.4% | 21.26% | 21.94% | 21.71% | 23.63% | 24.11% |
Net Margin | 0.63% | -3.73% | 13.47% | 13.14% | 3.86% | 5.7% | 4.66% | 4.54% | 5.23% |
Debt / Equity | 0.02x | - | 0.06x | 0.03x | 0.02x | 0.04x | 0.05x | 0.05x | 0.06x |
Interest Coverage | -6.95x | 166.84x | - | - | - | - | - | - | - |
FCF Conversion | 3.44x | 0.18x | 0.78x | 0.40x | 2.65x | 3.04x | 3.30x | 3.59x | 2.68x |
Revenue Growth | 116.94% | 117.92% | 50.15% | 45.17% | 57.19% | 38.34% | 7.22% | 10.4% | 6.59% |
Related:PGNY Dividend History·PGNY Revenue History·PGNY Price History·PGNY P/E History·PGNY Financial Ratios·PGNY Institutional Holders
PGNY SEC Filings & Documents
Progyny, Inc. (PGNY) SEC filings — annual & quarterly reports (10-K, 10-Q)
PGNY Frequently Asked Questions
Progyny, Inc. (PGNY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Progyny, Inc. (PGNY) reported $1.29B in revenue for fiscal year 2025. This represents a 2562% increase from $48.6M in 2017.
Progyny, Inc. (PGNY) grew revenue by 10.4% over the past year. This is steady growth.
Yes, Progyny, Inc. (PGNY) is profitable, generating $67.7M in net income for fiscal year 2025 (4.5% net margin).
Dividend & Returns
Progyny, Inc. (PGNY) has a return on equity (ROE) of 12.5%. This is reasonable for most industries.
Progyny, Inc. (PGNY) generated $181.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.